vimarsana.com
Home
Live Updates
IN8bio Announces Pricing of $10.25 Million Underwritten : vimarsana.com
IN8bio Announces Pricing of $10.25 Million Underwritten
NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery and...
Related Keywords
New York ,
United States ,
Robert Flamm ,
Patrick Mccall ,
David Buck ,
Exchange Commission ,
Company Contact ,
Burns Mcclellan Inc ,
Hc Wainwright Co ,
Nasdaq ,
Private Securities Litigation Reform Act ,
Registration Statement ,
Annual Report ,
Quarterly Report ,
Nasdaq Inab ,
In8bio ,
Nc ,
vimarsana.com © 2020. All Rights Reserved.